Target intelligence / Profile preview

5S ribosomal RNA pseudogene 230 (RNA5SP230)

Target
RNA5SP230
Molecular classification
Other, pseudogene, non-coding RNA pseudogene, rRNA pseudogene
01

Overview

5S ribosomal RNA pseudogene 230 (RNA5SP230) is a genomic DNA sequence derived from the 5S ribosomal RNA gene family but rendered nonfunctional due to accumulated mutations or truncations. Pseudogenes such as RNA5SP230 are neither transcribed into functional RNA nor play a direct biological or therapeutic role. Pseudogenes arise commonly through gene duplication followed by loss of function, or by retrotransposition events. They are categorized separately from canonical genes or therapeutic targets, and do not code for proteins or functional RNAs[6][4]. Unlike authentic 5S rRNA, which is crucial for ribosome structure and function in protein synthesis[3][1], pseudogenes such as RNA5SP230 have no current known biological function and are not implicated in disease, drug interaction, or clinical biomarker roles. Key points: - This entry is not a therapeutic target. It is a nonfunctional pseudogene and is generally excluded from target databases that focus on active biological macromolecules (e.g., receptors, enzymes, transporters)[4][6]. - The name is technically correct within the conventions of pseudogene cataloging, but the entity itself should not be treated as a drug or therapeutic target. Thus, for most research and therapeutic use cases, designating this as a target would be incorrect. - Aliases provided are standardized synonyms from genetics nomenclature but all refer to the same nonfunctional genetic element. - No known molecular function, disease relevance, drug interaction, biomarker use, or safety concern is associated. - Molecular classification: This is best classified as an "Other – Pseudogene" and specifically, an "rRNA pseudogene"[4]. If you require data for an active ribosomal RNA or gene product, 5S ribosomal RNA (functional gene) would be a legitimate biological entity, but RNA5SP230 is a pseudogene and functionally inert[3][6].

Other names
RN5S230RNA, 5S ribosomal 230RNA5SP230

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 230 (RNA5SP230).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 230 (RNA5SP230).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call